FDA Approves Replacement for Middle Joint in Arthritic Fingers

The U.S. Food and Drug Administration has approved a total replacement joint for patients suffering from arthritis of the middle joint in the finger, the proximal interphalangeal joint.

The Ascension®PIP PyroCarbon Total Joint -- a two-part, bi-condylar, semi-constrained prosthesis -- will expand limited treatment options presently available, providing a durable, wear-resistant joint with interchangeable parts.

"This (approval) will allow us to provide another solution to hand surgeons dealing with patients with debilitating arthritis," said Tim Seese, President and CEO of Ascension.

Ascension's Ascension® MCP was the first total joint finger implant of its kind to receive FDA approval.

Other sources:Ascension Orthopedics